• Users Online: 129
  • Print this page
  • Email this page
This article has been cited by
1Genetic burden linked to founder effects in Saguenay–Lac-Saint-Jean illustrates the importance of genetic screening test availability
Mbarka Bchetnia,Luigi Bouchard,Jean Mathieu,Philippe M Campeau,Charles Morin,Diane Brisson,Anne-Marie Laberge,Hélène Vézina,Daniel Gaudet,Catherine Laprise
Journal of Medical Genetics.2021;58(10)653
[DOI]
2Epidermolysis bullosa simplex clearance after nasopharyngeal carcinoma treatment
Nour Marwan AlKhawajah,Marwan Mohammed AlKhawajah,Nouf Abdulaziz Aljomah,Abeer Adeeb Alabduljabbar,Salim Alkeraye
JAAD Case Reports.2021;12(10)60
[DOI]
3A Novel Mutation p.L461P in KRT5 Causing Localized Epidermolysis Bullosa Simplex
Xin Jiang,Yingyu Zhu,Huihui Sun,Feng Gu
Annals of Dermatology.2021;33(1)11
[DOI]
4Management of epidermolysis bullosa simplex in pregnancy: A case report
Nidhi Shah,Sangeeta Kumaraswami,Juliet E. Mushi
Case Reports in Women's Health.2019;24(1)e00140
[DOI]
5Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa
Laura De Rosa,Elena Enzo,Giulia Zardi,Christine Bodemer,Cristina Magnoni,Holm Schneider,Michele De Luca
Frontiers in Genetics.2021;12(1)e00140
[DOI]
6Mesenchymal stromal cells in wound healing applications: role of the secretome, targeted delivery and impact on recessive dystrophic epidermolysis bullosa treatment
Julia Riedl,Courtney Popp,Cindy Eide,Christen Ebens,Jakub Tolar
Cytotherapy.2021;23(11)961
[DOI]
7Emerging drugs for the treatment of epidermolysis bullosa
Matthias Titeux,Mathilde Bonnet des Claustres,Araksya Izmiryan,Helene Ragot,Alain Hovnanian
Expert Opinion on Emerging Drugs.2020;25(4)467
[DOI]
8Losartan as disease modulating therapy for recessive dystrophic epidermolysis bullosa
Arun C. Inamadar
Dermatologic Therapy.2020;33(6)467
[DOI]
9QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study
Olivier Bornert,Marieke Hogervorst,Pauline Nauroy,Johannes Bischof,Jim Swildens,Ioannis Athanasiou,Sara F. Tufa,Douglas R. Keene,Dimitra Kiritsi,Stefan Hainzl,Eva M. Murauer,M. Peter Marinkovich,Gerard Platenburg,Ingrid Hausser,Verena Wally,Tita Ritsema,Ulrich Koller,Elisabeth M. Haisma,Alexander Nyström
Journal of Investigative Dermatology.2021;141(4)883
[DOI]
10Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa
Dimitra Kiritsi,Kathrin Dieter,Elke Niebergall-Roth,Silvia Fluhr,Cristina Daniele,Jasmina Esterlechner,Samar Sadeghi,Seda Ballikaya,Leoni Erdinger,Franziska Schauer,Stella Gewert,Martin Laimer,Johann W. Bauer,Alain Hovnanian,Giovanna Zambruno,May El Hachem,Emmanuelle Bourrat,Maria Papanikolaou,Gabriela Petrof,Sophie Kitzmüller,Christen L. Ebens,Markus H. Frank,Natasha Y. Frank,Christoph Ganss,Anna E. Martinez,John A. McGrath,Jakub Tolar,Mark A. Kluth
JCI Insight.2021;6(22)883
[DOI]
  Feedback 
  Subscribe 
  Search 
  Advanced Search 
  Apply as Reviewer